Skip to main content
. 2016 Jul 28;39(12):907–912. doi: 10.1038/hr.2016.96

Figure 1.

Figure 1

(a) Addition rates of each drug class as a second-line treatment after initial therapy with an ARB only and (b) the percentages of patients, stratified by age and sex, who initially received an ARB only. ARB, angiotensin II receptor blocker; BETA, β-blocker; CCB, calcium channel blocker; DIU, diuretic. Age was based on the index date of initial ARB prescription.